Traditional MIPS reporting ends after the 2030 performance period. CMS proposed 2028 in July, but the CY 2027 final rule, released November 4, 2026, adds two years, so every non-APM clinician must report an MIPS Value Pathway (MVP) starting with the 2031 performance period, which pays out in 2033.
The figures below come from the CMS fact sheet for the QPP section of the final rule and from Medical Economics coverage of the rule dated November 4, 2026. They matter to a practice manager because the MIPS score for 2027 sets the 2029 Medicare payment adjustment, which can reach -9.0%.
When traditional MIPS ends
CMS says it has signaled since 2019 that traditional MIPS would end. The July proposal set the end after the 2028 performance period. The final rule moves it to after the 2030 performance period, which is the 2032 payment year. CMS says the change allows an additional 2 years to pick an MVP, build workflows and set up subgroup data collection.
Clinicians in a MIPS APM keep the APM Performance Pathway (APP). Virtual groups can report an MVP starting with the 2029 performance period, per the CMS fact sheet. Medical Economics reports that MVPs cover about 98% of clinicians.
| Milestone | July 2026 proposal | November 2026 final rule |
|---|---|---|
| Last year of traditional MIPS | 2028 performance period | 2030 performance period |
| Last payment year of traditional MIPS | 2030 | 2032 |
| First MVP-only performance period | 2029 | 2031 (2033 payment year) |
| Virtual groups may report MVPs | Not stated | 2029 performance period |
Source: CMS, CY 2027 PFS Final Rule QPP Fact Sheet and Policy Comparison Table. The proposal sunset year (2028) is stated by CMS; the other proposal entries follow from it.
Three new MVPs bring the list to 30
CMS listed 27 MVPs for the 2026 performance period. The final rule adds 3 for 2027: Diabetic Disease, Hospitalist and Hypertension. That makes 30. CMS also changed all 27 existing MVPs to name their core measures, and it renamed the Rehabilitative Support for Musculoskeletal Care MVP to Rehabilitative Support.
A practice that waits until 2031 will pick from this list, but the choice shapes which measures it must collect. CMS says clinicians need time to build workflows for the measures in their MVP and systems to collect data at the subgroup level.
The quality category changes for 2027
The quality measure list shrinks from 190 measures in 2026 to 180 in 2027, excluding QCDR measures. CMS lists these moves behind the total:
- 2 measures added for prevention and chronic disease, one delayed to the 2028 performance period
- 4 QCDR measures adopted as MIPS measures
- 7 functional improvement measures replaced with 5 orthopedic functional outcome measures
- 20 measures removed
- 43 existing measures substantively changed
CMS drops the rule that each clinician report one outcome or high priority measure. In its place, CMS designates 78 measures as MIPS core measures. A traditional MIPS reporter must submit one core measure among 6 quality measures. An MVP reporter must submit one among 4. Small practices are exempt.
A clinician who is not a small practice and skips a core measure gets 0 out of 10 points on one required measure. The exception is an attestation that no core measure applies, plus a substitute measure. CMS also lets topped-out core measures escape the 7-point cap. They will score against a defined topped-out benchmark with a 10-point maximum, and 15 measures receive that benchmark for 2027.
Improvement activities and electronic prior authorization
The improvement activities list has 95 activities in 2026. For 2027, CMS adds 6, modifies 5 and removes 11.
The Electronic Prior Authorization measure becomes an optional bonus worth 10 points for the 2027 performance period. It becomes required with the 2028 performance period. A new Electronic Prior Authorization for Prescription Drugs measure is also required starting in 2028. CMS removes the Security Risk Analysis measure for 2027 and the two ONC attestations for 2026.
Data for the 2026 performance period is due between January 4 and March 31, 2027. A submission that still contains the ONC Direct Review or ONC-ACB Surveillance attestation will be rejected, per CMS.
Score thresholds stay put through 2028
CMS keeps the performance threshold at 75.00 points through the 2028 performance period, the 2030 payment year. The 2027 score sets the 2029 payment adjustment. CMS gives this scoring ladder:
| Final score | Payment impact |
|---|---|
| 0.00 to 18.75 points | -9.0% adjustment |
| 18.76 to 74.99 points | Negative adjustment between -9.0% and 0.0% |
| 75.00 points | Neutral, 0.0% |
| 75.01 to 100.00 points | Positive, with a budget neutrality scaling factor |
Source: CMS, CY 2027 PFS Final Rule QPP Fact Sheet, FAQ table.
The cost category has no new measures for 2027. The APP Plus quality set for ACOs drops 2 measures, Initiation and Engagement of Substance Use Disorder Treatment and Adult Immunization Status, and keeps 8.
What to do with the extra two years
Medical Economics ties the final rule to a 2.31% cut in the conversion factor for most physicians, from $33.40 to $32.63. A practice scoring at 75.00 points avoids a penalty, and the downside stays at -9.0% of Medicare Part B payments.
Before the 2027 performance year starts, a practice can find which of the 78 core measures its clinicians already report from EHR data. It can also test whether an MVP fits each specialty in the group. CMS expects historical 2027 benchmarks on the QPP website in late January 2027.
Sources
- CMS (hosted by the AMA), CY 2027 Medicare Physician Fee Schedule Final Rule: QPP Fact Sheet and Policy Comparison Table, November 2026
- Medical Economics, Medicare's final 2027 fee schedule cuts physician pay more than proposed but softens the same-day visit penalty, November 4, 2026
Talk to us
Fifteen minutes about your practice and the systems you run.